Scarica l'app Stockscreener
82.65
0.50%
0.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$82.03
Aprire:
$82.16
Volume 24 ore:
17,456
Relative Volume:
0.05
Capitalizzazione di mercato:
$1.86B
Reddito:
$747.40M
Utile/perdita netta:
$-12.60M
Rapporto P/E:
-107.52
EPS:
-0.7687
Flusso di cassa netto:
$105.18M
1 W Prestazione:
+0.38%
1M Prestazione:
-6.89%
6M Prestazione:
+31.31%
1 anno Prestazione:
+39.32%
Intervallo 1D:
$82.00
$82.99
Intervallo di 1 settimana:
$80.30
$83.60
Portata 52W:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Nome
Ani Pharmaceuticals Inc
Settore
Telefono
(218) 634-3500
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Confronta ANIP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
82.67 | 1.84B | 747.40M | -12.60M | 105.18M | -0.7687 |
|
ZTS
Zoetis Inc
|
119.28 | 52.03B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.51 | 45.40B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.61 | 42.13B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.71 | 34.19B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
485.51 | 20.88B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-03-12 | Iniziato | JP Morgan | Overweight |
| 2024-12-11 | Iniziato | Leerink Partners | Outperform |
| 2024-10-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-15 | Iniziato | CapitalOne | Overweight |
| 2023-08-22 | Reiterato | H.C. Wainwright | Buy |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-02 | Iniziato | Truist | Buy |
| 2020-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-05-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Reiterato | Canaccord Genuity | Buy |
| 2017-07-31 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-22 | Downgrade | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Iniziato | Raymond James | Strong Buy |
| 2016-05-24 | Downgrade | Standpoint Research | Buy → Hold |
| 2015-11-13 | Iniziato | Standpoint Research | Buy |
| 2015-09-28 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Reiterato | Oppenheimer | Outperform |
| 2015-08-04 | Reiterato | ROTH Capital | Neutral |
| 2015-07-31 | Reiterato | Oppenheimer | Outperform |
| 2015-07-15 | Reiterato | ROTH Capital | Neutral |
| 2015-06-23 | Reiterato | Oppenheimer | Outperform |
| 2015-05-18 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Reiterato | Oppenheimer | Outperform |
| 2015-04-10 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Reiterato | ROTH Capital | Buy |
| 2015-02-18 | Reiterato | Oppenheimer | Outperform |
Mostra tutto
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
ANI Pharmaceuticals Director Sold $146K In Company Stock - Benzinga
ANI Pharmaceuticals (NASDAQ:ANIP) Director Sells $146,070.00 in Stock - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Coverage Initiated by Analysts at Barclays - MarketBeat
Barclays Initiates ANI Pharmaceuticals at Overweight With $100 Price Target - marketscreener.com
ANI Pharmaceuticals (ANIP): Has the Recent Share Price Pullback Created a Valuation Opportunity? - Yahoo Finance
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by JPMorgan Chase & Co. - MarketBeat
Kennedy Capital Management LLC Reduces Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Is ANI Pharmaceuticals Inc. (BSFA) stock a buy for dividend portfoliosPortfolio Performance Report & Low Drawdown Investment Strategies - Newser
ANI Pharmaceuticals (ANIP): Valuation Check After Governance Shake-Up and New Rare Disease Strategy Moves - Sahm
Sio Capital Management LLC Buys 25,625 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Russell Investments Group Ltd. Decreases Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Can ANI Pharmaceuticals Inc. (BSFA) stock reach $200 price target2025 Market Outlook & Capital Efficient Trade Techniques - Newser
ANI Pharmaceuticals Announces Leadership Transition in Board - MSN
ANI Pharmaceuticals establishes FutureVision Advisory Council By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals Announces Formation of FutureVision Advisory Council to Help Strategically Guide Ophthalmology and Retina Franchise - marketscreener.com
ANI Pharmaceuticals, Inc. $ANIP Stock Position Lessened by Virtus Advisers LLC - MarketBeat
ANI Pharmaceuticals establishes FutureVision Advisory Council - Investing.com
Loomis Sayles & Co. L P Has $13.47 Million Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals Announces Formation of 'FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise - The Manila Times
ANI Pharmaceuticals Announces Formation of “FutureVision - GlobeNewswire
ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise - Sahm
ANI Pharmaceuticals (ANIP) Stock Analysis Report | Financials & Insights - Benzinga
Can ANI Pharmaceuticals Inc. (BSFA) stock stage a strong rebound this quarter2025 Momentum Check & Consistent Profit Trading Strategies - Newser
ANI Pharmaceuticals chairman Walsh to retire, Haughey elected successor By Investing.com - Investing.com Australia
ANI Pharmaceuticals announces board transition - marketscreener.com
ANI Pharmaceuticals Announces Board Transition - TradingView
ANI Pharmaceuticals' Chairman Patrick Walsh to Retire; Thomas Haughey Named Successor - marketscreener.com
ANI Pharmaceuticals chairman Walsh to retire, Haughey elected successor - Investing.com India
ANI Pharmaceuticals Announces Board Changes - TradingView
ANI Pharmaceuticals Announces Leadership Transition as Patrick D. Walsh Steps Down as Chairman, Thomas J. Haughey Elected as Successor - Quiver Quantitative
Elevation Point Wealth Partners LLC Invests $245,000 in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Does Recent Pipeline News Signal a New Opportunity for ANI Pharmaceuticals Stock in 2025? - Yahoo Finance
First Week of July 2026 Options Trading For ANI Pharmaceuticals (ANIP) - Nasdaq
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Dynamic Technology Lab Private Ltd Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Will ANI Pharmaceuticals Inc. stock attract ESG investorsJuly 2025 EndofMonth & Community Trade Idea Sharing - moha.gov.vn
Market Catalysts: Can ANI Pharmaceuticals Inc. stock deliver consistent earnings growthJuly 2025 Macro Moves & Real-Time Volume Analysis - BỘ NỘI VỤ
ANI Pharmaceuticals (ANIP): Assessing Valuation After Rare Disease Revenue Surges on Cortrophin Gel Demand - Sahm
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Universal Beteiligungs und Servicegesellschaft mbH Has $4.22 Million Holdings in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
CapEx per share of ANI Pharmaceuticals, Inc. – LSX:A1W15D - TradingView
Envestnet Asset Management Inc. Raises Stock Holdings in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. (ANIP) Stock forecasts - Yahoo Finance UK
What ANI Pharmaceuticals (ANIP)'s Rare Disease Revenue Surge Means for Shareholders - Sahm
ANI Pharmaceuticals, Inc. $ANIP Shares Acquired by Intech Investment Management LLC - MarketBeat
ANIP SEC FilingsAni Pharmaceutic 10-K, 10-Q, 8-K Forms - Stock Titan
Will ANI Pharmaceuticals Inc. stock maintain momentum in 2025Quarterly Trade Summary & Free Verified High Yield Trade Plans - newser.com
What high frequency data says about ANI Pharmaceuticals Inc.2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock deliver compounding returnsExit Point & Entry Point Confirmation Signals - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock remain on Wall Street radarQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Why hedge funds are buying ANI Pharmaceuticals Inc. stock2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.24%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):